Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers.

Biotechnology

Health Diagnostics

Life Sciences

Therapeutics

Inbiomotion

Inbiomotion's headquarters in Barcelona, Spain

Roger Gomis

Ralf van den Berg

Rob E. Coleman

Jon Askaa

Joël Jean-Mairet

Dan F. Hayes

José Antonio Mesa

Joan Albanell

David L. Lacey

Andrew Tutt

The Advisory and Governance team at Inbiomotion provides strategic guidance and oversight to ensure the company's mission aligns with industry standards and scientific advancements. Comprised of experienced professionals and leaders, this team advises on research directions, regulatory compliance, and business development, fostering effective governance for the company's innovative pursuit of personalized medicine in cancer care.

Advisory and Governance

The Leadership Team at Inbiomotion drives the strategic vision and operational execution of the company's mission to revolutionize cancer treatment through personalized medicine. Comprised of the founders and key executives, this team collaborates to oversee research initiatives, product development, and organizational growth while fostering partnerships to advance biomarker technology for predicting bone metastasis in cancer patients.

Leadership Team

Inbiomotion

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Inbiomotion

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Related companies